围生期心肌病相关血清学标志物的研究进展  

Serological Markers Related to Peripartum Cardiomyopathy

作　　者：赵小卫 蒋璐 ZHAO Xiaowei;JIANG Lu(Department of Obstetrics and Gynecology,Dazu Hospital Affiliated to Chongqing Medical University,Chongqing 400900,China;Department of General Medicine,Dazu Hospital Affiliated to Chongqing Medical University,Chongqing 400900,China)

机构地区：[1]重庆医科大学附属大足医院妇产科,重庆400900 [2]重庆医科大学附属大足医院全科医学科,重庆400900

出　　处：《心血管病学进展》2025年第3期245-248,共4页Advances in Cardiovascular Diseases

基　　金：重庆市大足区科卫联合医学科研项目(DZKJ2022JSYJ-KWXM1040);重庆市大足区科技发展项目(DZKJ2019ACC1023)。

摘　　要：围生期心肌病是一类罕见的围产期恶性心脏疾病,近年来发病率有升高趋势,但总体的相关研究报告较少。现对目前针对围生期心肌病相关血清学标志物的研究进行综述,从临床已开展检测的标志物和临床未开展检测的标志物两个角度进行描述。Peripartum cardiomyopathy is a rare perinatal malignant heart disease.In recent years,the incidence rate has an upward trend,but there are few related research reports.This article provides a review of current research on serological markers for peripartum cardiomyopathy,describing them from two perspectives:markers that have been clinically tested and markers that have not been clinically tested.

关 键 词：围生期心肌病 血清学 标志物 

分 类 号：R54[医药卫生—心血管疾病]